A report published in Circulation: Cardiovascular Quality and Outcomes found a faith-based program in traditionally black churches was able to lower systolic blood pressure among attendants by an average 5.8 mm Hg—a result that more typical public education programs failed to replicate.

Canon Medical Systems USA announced this week that it has launched a new program to help reduce injuries to sonographers.

The FDA has approved Siemens Healthineers’ MAGNETOM Sola, a 1.5 Tesla MRI scanner that utilizes the company's BioMatrix technology.

Healthcare companies were responsible for the most security events during the first half of 2018.

Patients who experience ischemic stroke in the posterior circulation are at greater risk of impaired functional outcomes compared to those with anterior circulation stroke (ACS)—particularly if their time to hospital arrival exceeds 4.5 hours, according to an Austrian registry study published Oct. 8 in Stroke.

International researchers have created an artificial intelligence (AI) method capable of automatically quantifying left ventricle (LV) function from cine MRIs, according to a multivendor, multicenter study published Oct. 9 in Radiology. Experts believe it may lead to faster cardiac MRI reporting.

Digoxin, a cardiac glycoside popularly sold under the brand name Lanoxin, poses a major threat to the heart health of atrial fibrillation (AF) and heart failure (HF) patients, according to a review published in the American Journal of Cardiology Oct. 4. Even without confounding conditions, the drug can raise an individual’s risk of all-cause mortality.

More millennials are forgoing the traditional route of having a primary care doctor in favor of using convenient urgent care centers and clinics for on-demand treatment when they are sick.

The Food and Drug Administration (FDA) has cleared the MAGNETOM Sola, a 1.5 Tesla magnetic resonance imaging (MRI) scanner from Siemens Healthineers that brings groundbreaking BioMatrix technology to the 1.5T market.

Measuring wall thickness in carotid arteries with MRI may help better determine cardiovascular disease risk assessment, according to research published Oct. 9 in Radiology.